Prevalence of multiple HPV infections in the study sample, HIV (−), and HIV (+) women (n = 1,129)
| HPV . | Overall, n = 1,129, n (%) . | HIV (−), n = 854, n (%) . | HIV (+), n = 275, n (%) . | Unadjusted OR (95% CI) . | Age-adjusted OR (95% CI) . | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Multiple HPV | ||||||||||
| Negative | 959 (84.9) | 757 (88.6) | 202 (73.5) | 1.00 | 1.00 | |||||
| Positive | 170 (15.1) | 97 (11.4) | 73 (26.5) | 2.82 (2.01-3.96) | 4.87 (3.25-7.29) | |||||
| No HPV | 702 (62.2) | 561 (65.7) | 141 (51.3) | 1.00 | 1.00 | |||||
| Single HR | 203 (18.0) | 156 (18.3) | 47 (17.1) | 1.19 (0.82-1.74) | 1.45 (0.97-2.16) | |||||
| Single LR | 54 (4.8) | 40 (4.7) | 14 (5.1) | 1.39 (0.73-2.63) | 1.96 (0.98-3.90) | |||||
| Multiple HR | 88 (7.8) | 63 (7.4) | 25 (9.1) | 1.57 (0.95-2.60) | 2.98 (1.70-5.25) | |||||
| Multiple LR+ | ||||||||||
| Multiple HR and LR | 82 (7.2) | 34 (3.9) | 48 (17.4) | 5.61 (3.48-9.04) | 10.08 (5.76-17.65) | |||||
| Number of HPV genotypes | Overall n (n)* | HIV (−) n (n)* | HIV (+) n (n)* | P | ||||||
| Mean (SD) | 0.64 (1.06) | 0.51 (0.86) | 1.02 (1.45) | <0.001 | ||||||
| 0 | 702 (723) | 561 (574) | 141 (149) | <0.001 | ||||||
| 1 | 257 (253) | 196 (189) | 61 (64) | |||||||
| 2 | 96 (100) | 59 (61) | 37 (39) | |||||||
| 3 | 41 (30) | 25 (23) | 16 (7) | |||||||
| ≥4 | 33 (23) | 13 (7) | 20 (16) | |||||||
| HPV . | Overall, n = 1,129, n (%) . | HIV (−), n = 854, n (%) . | HIV (+), n = 275, n (%) . | Unadjusted OR (95% CI) . | Age-adjusted OR (95% CI) . | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Multiple HPV | ||||||||||
| Negative | 959 (84.9) | 757 (88.6) | 202 (73.5) | 1.00 | 1.00 | |||||
| Positive | 170 (15.1) | 97 (11.4) | 73 (26.5) | 2.82 (2.01-3.96) | 4.87 (3.25-7.29) | |||||
| No HPV | 702 (62.2) | 561 (65.7) | 141 (51.3) | 1.00 | 1.00 | |||||
| Single HR | 203 (18.0) | 156 (18.3) | 47 (17.1) | 1.19 (0.82-1.74) | 1.45 (0.97-2.16) | |||||
| Single LR | 54 (4.8) | 40 (4.7) | 14 (5.1) | 1.39 (0.73-2.63) | 1.96 (0.98-3.90) | |||||
| Multiple HR | 88 (7.8) | 63 (7.4) | 25 (9.1) | 1.57 (0.95-2.60) | 2.98 (1.70-5.25) | |||||
| Multiple LR+ | ||||||||||
| Multiple HR and LR | 82 (7.2) | 34 (3.9) | 48 (17.4) | 5.61 (3.48-9.04) | 10.08 (5.76-17.65) | |||||
| Number of HPV genotypes | Overall n (n)* | HIV (−) n (n)* | HIV (+) n (n)* | P | ||||||
| Mean (SD) | 0.64 (1.06) | 0.51 (0.86) | 1.02 (1.45) | <0.001 | ||||||
| 0 | 702 (723) | 561 (574) | 141 (149) | <0.001 | ||||||
| 1 | 257 (253) | 196 (189) | 61 (64) | |||||||
| 2 | 96 (100) | 59 (61) | 37 (39) | |||||||
| 3 | 41 (30) | 25 (23) | 16 (7) | |||||||
| ≥4 | 33 (23) | 13 (7) | 20 (16) | |||||||
NOTE: Values in boldface are statistically significant at P < 0.05.
Abbreviations: HR, high-risk HPV; LR, low-risk HPV.
n, the frequency distribution after exclusion of clades A1, A4, A8, A11 and HPV54.